Clinical Trials Browser

Barrett Esophagus, Gastroesophageal Reflux, Gastrointestinal Neoplasms

Neoplasms, Recurrence

Leukemia, Myeloid, Acute

Astrocytoma, Glioma, Oligodendroglioma

Breast Neoplasms

Carcinoma in Situ, Uterine Cervical Dysplasia, Vulvar Diseases, Vulvar Neoplasms, Papillomavirus Infections

Lymphoma, Lymphoma, Non-Hodgkin, Hematologic Neoplasms

Prostatic Neoplasms

Lymphoma, T-Cell, Cutaneous, Lymphoma, T-Cell, Peripheral

Breast Neoplasms

Breast Neoplasms, Breast Neoplasms, Male

Breast Neoplasms

Neuroblastoma, Osteosarcoma

Breast Neoplasms

Colonic Neoplasms, Precancerous Conditions, Rectal Neoplasms, Colorectal Neoplasms

Breast Neoplasms

Lung Neoplasms

Astrocytoma, Ependymoma, Glioblastoma, Glioma, Oligodendroglioma, Glioma, Subependymal, Gliosarcoma

Breast Neoplasms

Carcinoma, Transitional Cell, Lung Neoplasms, Prostatic Neoplasms, Small Cell Lung Carcinoma

Metastatic Oncogen-driven Cancer

Burkitt Lymphoma, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Large-Cell, Anaplastic

Multiple Myeloma

Eye Diseases, Melanoma

Clinical Trials

GCC Agonist Signal in the Small Intestine

Peripheral T Cell Determinants of Response and Resistance to Pembrolizumab in Melanoma

MAPPYACTS

Cytarabine and Daunorubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia

SKINTARGET

Imiquimod and Pembrolizumab in Treating Patients With Stage IIIB-IV Melanoma

AB-218-IIT-201

SPAM

E7 TCR T Cells for Human Papillomavirus-Associated Cancers

Study of VIP152, Venetoclax, and Prednisone (VVIP) in Relapsed/Refractory Lymphoid Malignancies

Pertuzumab, Trastuzumab, Hyaluronidase-zzxf and Enzalutamide for Treatment of Metastatic Castration-Resistant Prostate Cancer

Romidepsin, CC-486 (5-azacitidine), Dexamethasone, and Lenalidomide (RAdR) for Relapsed/Refractory T-cell Malignancies

A Study Of Changes In PD-L1 Expression During Preoperative Treatment With Nab-Paclitaxel And Pembrolizumab In Hormone Receptor-Positive Breast Cancer

Molecular Mechanisms of Clinical Resistance to Targeted Therapy Among Patients With Breast Cancer

HKI-272 for HER2-Positive Breast Cancer and Brain Metastases

Testing the Combination of Two Immunotherapy Drugs (Magrolimab and Dinutuximab) in Patients With Relapsed or Refractory Neuroblastoma or Relapsed Osteosarcoma

Testing the Drug Atezolizumab or Placebo With Usual Therapy in First-Line HER2-Positive Metastatic Breast Cancer

Biological, Genetic, and Lifestyle Risk Factors for Developing Colorectal Adenomas or Polyps in Participants Undergoing Colonoscopy

NEO-ELASTO

Assessment of Tool Placement in Pulmonary Nodule(s) Using a Robotic Navigational Bronchoscopy System

Fluorine F 18 Fluorodopa-Labeled PET Scan in Planning Surgery and Radiation Therapy in Treating Patients With Newly Diagnosed High- or Low-Grade Malignant Glioma

Veliparib With or Without Carboplatin in Treating Patients With Stage III or IV Breast Cancer

Trial of EP0057, a Nanoparticle Camptothecin With Olaparib in People With Relapsed/Refractory Small Cell Lung Cancer

MATCH-R

Dose-Adjusted EPOCH Chemotherapy and Rituximab (CD20+) in Previously Untreated Aggressive Non-Hodgkin's Lymphoma

Testing the Addition of Ixazomib/Placebo to Lenalidomide in Patients With Evidence of Residual Multiple Myeloma, OPTIMUM Trial

Sentinel Lymph Node (SLN) Biopsy for Conjunctival/Eyelid Melanoma